Lee E - Search Results

1

Augmentation of cisplatin sensitivity in cisplatin-resistant human bladder cancer cells by modulating glutathione concentrations and glutathione-related enzyme activities.

Byun SS, Kim SW, Choi H, Lee C, Lee E. Byun SS, et al. Among authors: lee e, lee c. BJU Int. 2005 May;95(7):1086-90. doi: 10.1111/j.1464-410X.2005.05472.x. BJU Int. 2005. PMID: 15839938

2

Upregulation of Bcl-2 is associated with cisplatin-resistance via inhibition of Bax translocation in human bladder cancer cells.

Cho HJ, Kim JK, Kim KD, Yoon HK, Cho MY, Park YP, Jeon JH, Lee ES, Byun SS, Lim HM, Song EY, Lim JS, Yoon DY, Lee HG, Choe YK. Cho HJ, et al. Cancer Lett. 2006 Jun 8;237(1):56-66. doi: 10.1016/j.canlet.2005.05.039. Epub 2005 Jul 11. Cancer Lett. 2006. PMID: 16009487

3

Upregulated expression of BCL2, MCM7, and CCNE1 indicate cisplatin-resistance in the set of two human bladder cancer cell lines: T24 cisplatin sensitive and T24R2 cisplatin resistant bladder cancer cell lines.

Kim SH, Ho JN, Jin H, Lee SC, Lee SE, Hong SK, Lee JW, Lee ES, Byun SS. Kim SH, et al. Investig Clin Urol. 2016 Jan;57(1):63-72. doi: 10.4111/icu.2016.57.1.63. Epub 2016 Jan 11. Investig Clin Urol. 2016. PMID: 26966728 Free PMC article.

4

The role of c-FLIP in cisplatin resistance of human bladder cancer cells.

Lee S, Yoon CY, Byun SS, Lee E, Lee SE. Lee S, et al. Among authors: lee e, lee se. J Urol. 2013 Jun;189(6):2327-34. doi: 10.1016/j.juro.2013.01.003. Epub 2013 Jan 9. J Urol. 2013. PMID: 23313194

5

Synergistic antitumor effect of ginsenoside Rg3 and cisplatin in cisplatin‑resistant bladder tumor cell line.

Lee YJ, Lee S, Ho JN, Byun SS, Hong SK, Lee SE, Lee E. Lee YJ, et al. Among authors: lee e, lee s, lee se. Oncol Rep. 2014 Nov;32(5):1803-8. doi: 10.3892/or.2014.3452. Epub 2014 Aug 29. Oncol Rep. 2014. PMID: 25175462

6

Antitumor effects of MutT homolog 1 inhibitors in human bladder cancer cells.

Lee JW, Lee S, Ho JN, Youn JI, Byun SS, Lee E. Lee JW, et al. Among authors: lee e, lee s. Biosci Biotechnol Biochem. 2019 Dec;83(12):2265-2271. doi: 10.1080/09168451.2019.1648207. Epub 2019 Jul 31. Biosci Biotechnol Biochem. 2019. PMID: 31362565

7

Initial tumor stage and grade as a predictive factor for recurrence in patients with stage T1 grade 3 bladder cancer.

Kwak C, Ku JH, Park JY, Lee E, Lee SE, Lee C. Kwak C, et al. Among authors: lee e, lee c, lee se. J Urol. 2004 Jan;171(1):149-52. doi: 10.1097/01.ju.0000099825.98542.a8. J Urol. 2004. PMID: 14665864 Review.

8

Expression of survivin in renal cell carcinomas: association with pathologic features and clinical outcome.

Byun SS, Yeo WG, Lee SE, Lee E. Byun SS, et al. Among authors: lee e, lee se. Urology. 2007 Jan;69(1):34-7. doi: 10.1016/j.urology.2006.09.024. Urology. 2007. PMID: 17270609

9

Gender-specific clinicopathological features and survival in patients with renal cell carcinoma (RCC).

Lee S, Jeon HG, Kwak C, Kim HH, Byun SS, Lee SE, Lee E. Lee S, et al. Among authors: lee e, lee se. BJU Int. 2012 Jul;110(2 Pt 2):E28-33. doi: 10.1111/j.1464-410X.2011.10667.x. Epub 2011 Nov 15. BJU Int. 2012. PMID: 22085161

10

Analysis of resistance-associated gene expression in docetaxel-resistant prostate cancer cells.

Lee S, Kim K, Ho JN, Jin H, Byun SS, Lee E. Lee S, et al. Among authors: lee e. Oncol Lett. 2017 Sep;14(3):3011-3018. doi: 10.3892/ol.2017.6541. Epub 2017 Jul 8. Oncol Lett. 2017. PMID: 28928839 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23,826 results

Search Page

Filters